𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prevalence and type distribution of high-risk human papillomavirus infection in women undergoing voluntary cervical cancer screening in Italy

✍ Scribed by Alberto Agarossi; Enrico Ferrazzi; Fabio Parazzini; Carlo Federico Perno; Luciano Ghisoni


Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
105 KB
Volume
81
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The aim of this survey was to assess the prevalence and distribution of oncogenic human papillomavirus (HPV) genotypes in women who underwent screening for cervical cancer in Italy. The correlation of genotypes with the cytological results was also evaluated. Cervical samples were collected from 9,947 self‐referring women for cervical cancer screening. Participants were screened by liquid‐based cytology and high‐risk HPV testing using the Hybrid Capture 2 test. Positive samples were genotyped by PCR. Samples (1,474; 14.8%) were positive for high‐risk HPV. The prevalence was 29.4% in the 15–19 years‐group, decreasing progressively to 6.1% at 50–54 years of age and increasing to 12.2% in those aged over 65 years. HPV 16 was the genotype detected most frequently followed by HPV 31, HPV 18, HPV 56, and HPV 51. HPV 16 or 18 were present in 4% of women with normal cytology and both were detected contemporarily in only 14 women. Twenty‐two percent of atypical squamous cells, 26% of low‐grade and 56% of high‐grade squamous intraepithelial lesions at cytology were positive for HPV 16 and/or 18. The prevalence of HPV infection in Italy is in agreement with that reported worldwide. HPV 16 was the prevalent genotype. The concomitant infection with HPV 16 and HPV 18 (vaccine targets) was found rarely. Apart from HPV 16 and 18, there was a substantial presence of HPV genotypes against which the vaccines available currently have shown cross‐protection efficacy. The findings of this study may contribute to reliable predictions on the potential efficacy of an HPV vaccine in clinical practice. J. Med. Virol. 81:529–535, 2009. © 2009 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


High prevalence of intermediate-risk hum
✍ Mosfequr Rahman; Toshiyuki Sasagawa; Rika Yamada; Alan Kingoro; Hiroshi Ichimura 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB

## Abstract The aim of this study was to investigate an association between certain human papillomavirus (HPV) types and human immunodeficiency virus (HIV) infections. Sexually active females (n = 487; 19–61 years old) were enrolled in the study. Subjects underwent Pap testing and evaluations of HI

High prevalence of human papillomavirus
✍ Chan, Paul K.S.; Li, Wai-Hon; Chan, May Y.M.; Ma, Wei-Ling; Cheung, Jo L.K.; Che 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 245 KB 👁 1 views

The prevalence of human papillomavirus (HPV) among 332 Hong Kong Chinese women with abnormal Papanicolaou smears were determined by polymerase chain reaction and restriction fragment length polymorphism analysis. The overall HPV positive rate was 44.3% with 18.6% (16/86) for normal/inflamed cervices

Typing of human papillomavirus in women
✍ Maria Teresa Sandri; Daniela Riggio; Michela Salvatici; Rita Passerini; Laura Zo 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

## Abstract Human papillomavirus (HPV) are distributed widely and persistent infection with high‐risk (HR) HPV is recognized as a necessary cause of cervical cancer. The aim of this study was to evaluate the distribution of different HR‐HPV genotypes in 199 women with cervical pre‐invasive lesions

Population-based type-specific prevalenc
✍ Ola Forslund; Annika Antonsson; Karin Edlund; Adrian J.C. van den Brule; Bengt-G 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB

## Abstract Human papillomavirus (HPV) DNA testing can be used to identify women at risk of the development of cervical cancer. The cost‐effectiveness of HPV screening is dependent on the type‐specific HPV prevalence in the general population. The present study describes the prevalence and spectrum

Natural history and screening model for
✍ Johannes Berkhof; Martine C de Bruijne; Gilda D Zielinski; Chris JLM Meijer 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 126 KB 👁 2 views

## Abstract A simulation model is presented that assumes that persistent infection with high‐risk human papillomavirus (hrHPV) is a necessary cause of cervical cancer. For the estimation of the model parameters, data of recent Dutch follow‐up studies were reanalyzed. The predicted incidences of cer

Prevalence of types 16 and 33 is increas
✍ Nicole W.J. Bulkmans; Maaike C.G. Bleeker; Johannes Berkhof; Feja J. Voorhorst; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 82 KB 👁 2 views

## Abstract High‐risk human papillomavirus (hrHPV) types are causally related to cervical cancer and its high‐grade precursor lesions. The risk posed by the different hrHPV types for the development of cervical intraepithelial neoplasia grade 2 or worse (≥CIN2) needs to be established. Here, we pre